AzTrials
AzTrials

Geriatric CareMAYFAIRNCT06080126

Developing and Implementing Meaningful Activities Facilitators in Geriatric Short Stay

A study testing Intervention MAF in people with Geriatric Care, run by Hospices Civils de Lyon at 2 sites in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Older people are particularly vulnerable to adverse effects of hospitalization, which can compromise their functional autonomy. The onset of confusion, loss of mobility or malnutrition is largely related to the context of hospitalization itself, which creates stressful situations for patients in addition to the acute… Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Geriatric Care
What is being tested?
Intervention MAF
Could I receive a placebo?
No, everyone receives an active treatment
How many people
320 participants
Where
2 sitesFrance
Study dates
30 Oct 2023to 30 Apr 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Patient aged 65 and over
  • admitted to a geriatric short-stay hospital for > 72 hours
  • Considered "at risk of complications related to hospitalisation": at least two of the following criteria:
  • Clinical Frailty Scale (Rockwood Clinical Frailty Score
  • At least one ADL-IADL dependency,
  • Presence of known cognitive impairment,
Show all 15Show fewer
  • Patient confused on admission,
  • History of confusional syndrome on previous hospitalisation or use of medication,
  • Anxiety-depression (history or current pathology),
  • Repeated falls (>2 in a year) or fear of falling,
  • Risk of sarcopenia (Score >4 on the SARC-F questionnaire
  • Presenting undernutrition or a risk of undernutrition (according to medical assessment, e.g. low BMI, anorexia, recent weight loss).
  • Patient having been informed of the study and having signed an informed consent (for patients under guardianship, the consent of the guardian will be requested). For patients under guardianship, the patient will sign the consent in the presence of the guardian.
  • Patient who understands and speaks French
  • Patient affiliated to a social security scheme

Who cannot join

  • Patient in palliative care for a terminal disease
  • Re-hospitalised patients already included during a previous stay
  • Patients under court protection

Trial locations and contacts

2 sites in 1 country.

France2 sites
  • Geriatric Short Stay Department - Unit 3C of the Charpennes Hospital

    Lyon, 69100

    Antoine CRUSSARD-GARNIER, MD, 4.72.43.21.27 ext. +33, antoine.garnier-crussard@chu-lyon.fr

  • University Department of Geriatric Medicine, Centre Hospitalier Lyon Sud

    Lyon, 69495

    Thomas GILBERT, MD, 4.78.86.49.39 ext. +33, thomas.gilbert@chu-lyon.fr

    Stephanie POUPON-BOURDY, 6.61.23.43.28, stephanie.poupon-bourdy@chu-lyon.fr

Other trials in France

About this study

Official title: Developing and Implementing Meaningful Activities Facilitators in Short-stay Geriatric Unit to Prevent Geriatric Complication - A Feasibility Study

Older people are particularly vulnerable to adverse effects of hospitalization, which can compromise their functional autonomy. The onset of confusion, loss of mobility or malnutrition is largely related to the context of hospitalization itself, which creates stressful situations for patients in addition to the acute pathology: change in the usual living environment, lack of human and reassuring interactions, lack of mobility related to the pathology or caused by the use of barriers or restraints. These geriatric complications can be prevented. Programs involving the intervention of volunteers or dedicated professionals with hospitalized patients have been developed. These "Meaningful Activities Facilitators" (MAF) have the task of preventing or limiting the deleterious effects of hospitalization on the older people, in particular by stimulating eating and walking, and by practicing social activities in line with the patient's lifestyle habits. This system has been set up in geriatric short-stay wards in the United Kingdom, where MAFs, who received specific training, are integrated into the care team and work with patients at risk. The integration of these MAFs has shown a reduction in the incidence and duration of delirium episodes, the use of psychotropic drugs, and the use of restraint. A study currently underway in Australia aims to reduce hospital-acquired complications through a program of mobilization, nutrition, and engagement of patients in constructive activities (the "Eat, Walk, Engage" program) implemented by a trained MAFs. The investigators hypothesis is that the implementation of MAFs in geriatric short-stay wards will reduce the incidence of geriatric complications associated with hospitalization.

Objectives: The investigators objective is to study the feasibility and acceptability of integrating MAFs into the care teams of two geriatric short-stay services in France. The investigators will evaluate the adaptations to be proposed to the MAF model to make it relevant in our context from the point of view of patients, their relatives and professionals, and will study the effect of this intervention on the occurrence of complications and the functioning of the teams, its implementation and its costs.

Perspectives: The results of this study will allow us to define if the MAFs intervention is feasible and acceptable in the French context, and if so, to propose an intervention model adapted to our context.

Read the detailed description

Methods: The project will be carried out in 2 phases guided by the Medical Research Council's (MRC) recommendations for the development and evaluation of complex health interventions. Phase 1: Adaptation of the MAFs intervention to our context, combining literature review, non-participant observation, semi-structured interviews, and coconstruction workshops. Phase 2: Feasiblity testing : A quasi-experimental feasibility "before and after" study will be conducted in two geriatric short-stay services on 380 patients: "before" period over 4 months (inclusion of 160 hospitalized patients constituting the control group), recruitment and training of 2 MAFs, implementation of the intervention, "after" period over 4 months (inclusion of 160 hospitalized patients constituting the intervention group). The patients will be included at admission and followed up during the hospital stay. The data collected concern the occurrence of complications during the stay, the quality of life at work of the professionals, and in the "after" period, the acceptability and fidelity of the MAFs intervention, according to the point of view of the MAFs, the professionals and the patients/relatives. These criteria will be collected through monitoring of the MAFs activity (logbook, medical records) and semi-structured interviews. The impact of the integration of the MAFs on the functioning, team cohesion and collaboration will be studied.

The results will allow us to propose phase 3 of the MRC recommendations, a multicenter randomized controlled evaluation in clusters, informed by the results for the content of the intervention, the implementation strategies, the choice of the primary endpoint, the inclusion criteria of the population, the calculation of the sample size and the study procedures (inclusion, data collection).

Conditions
Geriatric Care
Being tested
Control: per usual practice, Intervention MAF
Keywords
Meaningful activities facilitators, geriatric service

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Control: per usual practiceOther

    160 patients were included as per usual practice.

  • Intervention MAFOther

    160 patients were included with MAF intervention.

Study groups in NCT06080126
Study groupRoleWhat they receive
ControlOtherNot described
Receives: Other: Control: per usual practice
InterventionOtherNot described
Receives: Other: Intervention MAF

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Feasibility and acceptability of implementing meaningful activities facilitators (MAF) in a French short stay geriatric unit, from the perspective of professionals, MAF and patients/relatives.

    Criteria to conclude on feasibility will be the fulfilment of the following criteria during the intervention period (MAF implementation):

    • employment of two MAFs (one per participating unit, 0.5FTE),
    • SATIN and EEPMT Questionnaire

    Measured: From the implementation of a meaningful activities facilitators for a period of 4 months.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Oct 2023
  2. Study start30 Oct 2023 (estimated)
  3. Primary completion31 Dec 2024 (estimated)
  4. Study completion30 Apr 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
The study will be conducted in a 2-phase approach corresponding to the 2 successive phases of the MRC guidance: * Phase 1: The adaptation of the intervention to our context will be based on a literature review and a qualitative study. * Phase 2: The feasibility and acceptability of the intervention will be assessed during a quasi-experimental before and after study conducted in two short-stay geriatric units.
Masking
None (open label)
Enrolment
320 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06080126
Sponsor's protocol ID
69HCL22_0726
Other IDs
2023-A00490-45
Acronym
MAYFAIR
Status last verified
Sep 2023
First submitted
21 Sep 2023
Last updated
17 Oct 2023
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Intervention MAF in people with Geriatric Care, run by Hospices Civils de Lyon at 2 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 15 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 17 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Thomas GILBERT, MD (4.78.86.49.39 ext. +33, thomas.gilbert@chu-lyon.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Feasibility and acceptability of implementing meaningful activities facilitators (MAF) in a French short stay geriatric unit, from the perspective of professionals, MAF and patients/relatives. (time frame: From the implementation of a meaningful activities facilitators for a period of 4 months.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 17 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in